Mark A Dubbelman, Jori Tomassen, Sophie M van der Landen, Els Bakker, Suzie Kamps, Annemartijn A J M van Unnik, Marie-Christine A B J van de Glind, Annelies E van der Vlies, Ted Koene, Anna E Leeuwis, Frederik Barkhof, Argonde C van Harten, Charlotte Teunissen, Elsmarieke van de Giessen, Afina W Lemstra, Yolande A L Pijnenburg, Rudolf W H Ponds, Sietske A M Sikkes
{"title":"通过视觉联想学习检测早期外显记忆缺陷,区分阿尔茨海默病和其他类型的痴呆症。","authors":"Mark A Dubbelman, Jori Tomassen, Sophie M van der Landen, Els Bakker, Suzie Kamps, Annemartijn A J M van Unnik, Marie-Christine A B J van de Glind, Annelies E van der Vlies, Ted Koene, Anna E Leeuwis, Frederik Barkhof, Argonde C van Harten, Charlotte Teunissen, Elsmarieke van de Giessen, Afina W Lemstra, Yolande A L Pijnenburg, Rudolf W H Ponds, Sietske A M Sikkes","doi":"10.1017/S1355617724000079","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>We investigated how well a visual associative learning task discriminates Alzheimer's disease (AD) dementia from other types of dementia and how it relates to AD pathology.</p><p><strong>Methods: </strong>3,599 patients (63.9 ± 8.9 years old, 41% female) from the Amsterdam Dementia Cohort completed two sets of the Visual Association Test (VAT) in a single test session and underwent magnetic resonance imaging. We performed receiver operating curve analysis to investigate the VAT's discriminatory ability between AD dementia and other diagnoses and compared it to that of other episodic memory tests. We tested associations between VAT performance and medial temporal lobe atrophy (MTA), and amyloid status (<i>n</i> = 2,769, 77%).</p><p><strong>Results: </strong>Patients with AD dementia performed worse on the VAT than all other patients. The VAT discriminated well between AD and other types of dementia (area under the curve range 0.70-0.86), better than other episodic memory tests. Six-hundred forty patients (17.8%) learned all associations on VAT-A, but not on VAT-B, and they were more likely to have higher MTA scores (odds ratios range 1.63 (MTA 0.5) through 5.13 for MTA ≥ 3, all <i>p</i> < .001) and to be amyloid positive (odds ratio = 3.38, 95%CI = [2.71, 4.22], <i>p</i> < .001) than patients who learned all associations on both sets.</p><p><strong>Conclusions: </strong>Performance on the VAT, especially on a second set administered immediately after the first, discriminates AD from other types of dementia and is associated with MTA and amyloid positivity. The VAT might be a useful, simple tool to assess early episodic memory deficits in the presence of AD pathology.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Visual associative learning to detect early episodic memory deficits and distinguish Alzheimer's disease from other types of dementia.\",\"authors\":\"Mark A Dubbelman, Jori Tomassen, Sophie M van der Landen, Els Bakker, Suzie Kamps, Annemartijn A J M van Unnik, Marie-Christine A B J van de Glind, Annelies E van der Vlies, Ted Koene, Anna E Leeuwis, Frederik Barkhof, Argonde C van Harten, Charlotte Teunissen, Elsmarieke van de Giessen, Afina W Lemstra, Yolande A L Pijnenburg, Rudolf W H Ponds, Sietske A M Sikkes\",\"doi\":\"10.1017/S1355617724000079\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>We investigated how well a visual associative learning task discriminates Alzheimer's disease (AD) dementia from other types of dementia and how it relates to AD pathology.</p><p><strong>Methods: </strong>3,599 patients (63.9 ± 8.9 years old, 41% female) from the Amsterdam Dementia Cohort completed two sets of the Visual Association Test (VAT) in a single test session and underwent magnetic resonance imaging. We performed receiver operating curve analysis to investigate the VAT's discriminatory ability between AD dementia and other diagnoses and compared it to that of other episodic memory tests. We tested associations between VAT performance and medial temporal lobe atrophy (MTA), and amyloid status (<i>n</i> = 2,769, 77%).</p><p><strong>Results: </strong>Patients with AD dementia performed worse on the VAT than all other patients. The VAT discriminated well between AD and other types of dementia (area under the curve range 0.70-0.86), better than other episodic memory tests. Six-hundred forty patients (17.8%) learned all associations on VAT-A, but not on VAT-B, and they were more likely to have higher MTA scores (odds ratios range 1.63 (MTA 0.5) through 5.13 for MTA ≥ 3, all <i>p</i> < .001) and to be amyloid positive (odds ratio = 3.38, 95%CI = [2.71, 4.22], <i>p</i> < .001) than patients who learned all associations on both sets.</p><p><strong>Conclusions: </strong>Performance on the VAT, especially on a second set administered immediately after the first, discriminates AD from other types of dementia and is associated with MTA and amyloid positivity. The VAT might be a useful, simple tool to assess early episodic memory deficits in the presence of AD pathology.</p>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://doi.org/10.1017/S1355617724000079\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1017/S1355617724000079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
Visual associative learning to detect early episodic memory deficits and distinguish Alzheimer's disease from other types of dementia.
Objective: We investigated how well a visual associative learning task discriminates Alzheimer's disease (AD) dementia from other types of dementia and how it relates to AD pathology.
Methods: 3,599 patients (63.9 ± 8.9 years old, 41% female) from the Amsterdam Dementia Cohort completed two sets of the Visual Association Test (VAT) in a single test session and underwent magnetic resonance imaging. We performed receiver operating curve analysis to investigate the VAT's discriminatory ability between AD dementia and other diagnoses and compared it to that of other episodic memory tests. We tested associations between VAT performance and medial temporal lobe atrophy (MTA), and amyloid status (n = 2,769, 77%).
Results: Patients with AD dementia performed worse on the VAT than all other patients. The VAT discriminated well between AD and other types of dementia (area under the curve range 0.70-0.86), better than other episodic memory tests. Six-hundred forty patients (17.8%) learned all associations on VAT-A, but not on VAT-B, and they were more likely to have higher MTA scores (odds ratios range 1.63 (MTA 0.5) through 5.13 for MTA ≥ 3, all p < .001) and to be amyloid positive (odds ratio = 3.38, 95%CI = [2.71, 4.22], p < .001) than patients who learned all associations on both sets.
Conclusions: Performance on the VAT, especially on a second set administered immediately after the first, discriminates AD from other types of dementia and is associated with MTA and amyloid positivity. The VAT might be a useful, simple tool to assess early episodic memory deficits in the presence of AD pathology.